To access this content, you must be a member. Visit the Plans page for details.
Driehaus lobbies against Towers Watson-Willis deal
Driehaus Capital Management, a 1% shareholder in Towers Watson, is lobbying against the merger between Towers Watson and Willis Group [Read More]